As per the latest report by Renub Research titled "Oncology Precision Medicine Market, Size, Global Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" the Global Oncology Precision Market Size will reach USD 64.66 Billion by 2027. Oncology precision medicine is an emerging trend in the healthcare industry that has been growing quickly in recent years. It makes the diagnosis of cancer and other diseases more accurate and evaluates the specific genetic makeup of their tumors to select the safest and most effective treatments for them. In cancer, precision medicine involves sampling DNA from patients' tumors to determine the mutations or other genetic changes that drive their cancer. Physicians then may select a treatment for a particular patient's cancer that best matches, or targets, the culprit mutations in the tumor DNA.
Likewise, some of the more common cancers where precision medicine is being used to help with treatment decision
